Screener
Sarepta Therapeutics, Inc. SRPT Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Right of use assets | 120,847 | 125,495 |
| Non-current inventory | 226,333 | 184,543 |
| Non-current investments | 145,372 | 1,048 |
| Other non-current assets | 146,145 | 155,554 |
| Total assets | $3,188,512 | $3,349,703 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $50,982 | $280,841 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s other non-current assets?
- Sarepta Therapeutics, Inc. (SRPT) reported other non-current assets of $146.15M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s other non-current assets changed year-over-year?
- Sarepta Therapeutics, Inc.'s other non-current assets increased by 75.8% year-over-year, from $83.14M to $146.15M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s other non-current assets has grown at a -5.3% compound annual growth rate (CAGR), from $203.7M to $155.55M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Sarepta Therapeutics, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude